![Jing Marantz](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jing Marantz
Hoofd Techniek/Wetenschap/O&O bij
SCHOLAR ROCK HOLDING CORPORATION
Vermogen: 6 M $ op 31-05-2026
Profiel
Dr. Jing L. Marantz is Senior Vice President-Medical Affairs bij Acceleron Pharma, Inc. Zij zit in de Raad van Bestuur van Krystal Biotech, Inc. Dr. Marantz was voorheen werkzaam als Hoofd Medische Zaken & Senior Vice President bij Alnylam Pharmaceuticals, Inc., als Vice President Medische Zaken bij ARIAD Pharmaceuticals, Inc., en als Vice President-Global Medical Affairs bij Alexion Pharmaceuticals, Inc. Zij behaalde haar MBA aan de Haas School of Business, een doctorstitel aan het Tongji Medical College van de Huazhong University of Sci & Tech en een doctorstitel aan de Medical University of South Carolina.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 17-02-2026 | 126.012 ( 0,11% ) | 6 M $ | 31-05-2026 | |
| 05-06-2026 | 0 ( -.--% ) | - $ | 31-05-2026 |
Actieve functies van Jing Marantz
| Bedrijven | Functie | Begin |
|---|---|---|
| ARCTURUS THERAPEUTICS HOLDINGS INC. | Directeur/Bestuurslid | 07-12-2021 |
| SCHOLAR ROCK HOLDING CORPORATION | Hoofd Techniek/Wetenschap/O&O | 09-11-2022 |
Arcturus Therapeutics Ltd.
 Arcturus Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops technology and therapeutics for rare diseases | Directeur/Bestuurslid | - |
Arcturus Therapeutics, Inc.
 Arcturus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops technology and therapeutics for rare diseases | Directeur/Bestuurslid | - |
Eerdere bekende functies van Jing Marantz
| Bedrijven | Functie | Einde |
|---|---|---|
| KRYSTAL BIOTECH, INC. | Directeur/Bestuurslid | 18-01-2022 |
| ACCELERON PHARMA INC. | Hoofd Techniek/Wetenschap/O&O | 01-11-2021 |
| ALNYLAM PHARMACEUTICALS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-09-2020 |
| ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01-06-2018 |
| ARIAD PHARMACEUTICALS, INC. | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Jing Marantz
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
45
Eerstegraads connecties
11
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 11 |
|---|---|
ARIAD Pharmaceuticals, Inc.
 ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes small-molecule drugs for the treatment of cancer | Health Technology |
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops life-changing therapies for people living with rare disorders | Health Technology |
Acceleron Pharma, Inc.
 Acceleron Pharma, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company which develops protein therapeutics for cancer and orphan diseases | Health Technology |
Arcturus Therapeutics, Inc.
Arcturus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops technology and therapeutics for rare diseases | Health Technology |
Alnylam Pharmaceuticals, Inc.
 Alnylam Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics based on RNA interference | Health Technology |
Medical University of South Carolina
 Medical University of South Carolina Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Krystal Biotech, Inc.
 Krystal Biotech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops gene therapies to patients living with debilitating diseases | Health Technology |
Arcturus Therapeutics Ltd.
Arcturus Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops technology and therapeutics for rare diseases | Health Technology |
Scholar Rock Holding Corp.
 Scholar Rock Holding Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company that focused on the discovery, development and delivery medicines for neuromuscular, cardiometabolic disorders, cancer, fibrosis and iron-restricted anemia | Health Technology |
Arcturus Therapeutics Holdings, Inc.
 Arcturus Therapeutics Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
